Resolving controversies on the path to Alzheimer's therapeutics

被引：416

作者：

Selkoe, Dennis J. ^{[1
]}

机构：

[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA

来源：

NATURE MEDICINE | 2011年 / 17卷 / 09期

关键词：

APOLIPOPROTEIN-E GENOTYPE; TAU-HYPERPHOSPHORYLATION; SYNAPTIC PLASTICITY; AMYLOID HYPOTHESIS; DISEASE; IMMUNIZATION; DEPOSITION; MISSENSE; GENE; DEGENERATION;

D O I：

10.1038/nm.2460

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Alzheimer's disease constitutes a personal and societal tragedy of immense proportions. Since 1960, research in laboratories and clinics worldwide has elucidated many features of this insidious and ultimately fatal syndrome, and this progress has led to initial human trials of potentially disease-modifying agents. However, some of these agents have already failed. Gnawing controversies and important gaps in our knowledge seem to cast additional doubt on the ability of the field to move forward effectively. Here I discuss some of these looming concerns and offer possible explanations for the major trial failures that suggest they are not predictive of the future. Rigorous preclinical validation of mechanism-based therapeutic agents followed by meticulously designed trials that focus on the cardinal cognitive symptoms and their associated biomarkers in the mild or presymptomatic phases of Alzheimer's disease are likely to lead to success, perhaps in the not-too-distant future.

引用

页码：1060 / 1065

页数：6

共 38 条

[21] Plaque-induced neurite abnormalities: Implications for disruption of neural networks in Alzheimer's disease [J].

Knowles, RB ;

Wyart, C ;

Buldyrev, SV ;

Cruz, L ;

Urbanc, B ;

Hasselmo, ME ;

Stanley, HE ;

Hyman, BT .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (09) :5274-5279

[22] Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques [J].

Koffie, Robert M. ;

Meyer-Luehmann, Melanie ;

Hashimoto, Tadafumi ;

Adams, Kenneth W. ;

Mielke, Matthew L. ;

Garcia-Alloza, Monica ;

Micheva, Kristina D. ;

Smith, Stephen J. ;

Kim, M. Leo ;

Lee, Virginia M. ;

Hyman, Bradley T. ;

Spires-Jones, Tara L. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (10) :4012-4017

[23] Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: Implications for initial events in amyloid plaque formation [J].

Lemere, CA ;

Blusztajn, JK ;

Yamaguchi, H ;

Wisniewski, T ;

Saido, TC ;

Selkoe, DJ .

NEUROBIOLOGY OF DISEASE, 1996, 3 (01) :16-32

[24] Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP [J].

Lewis, J ;

Dickson, DW ;

Lin, WL ;

Chisholm, L ;

Corral, A ;

Jones, G ;

Yen, SH ;

Sahara, N ;

Skipper, L ;

Yager, D ;

Eckman, C ;

Hardy, J ;

Hutton, M ;

McGowan, E .

SCIENCE, 2001, 293 (5534) :1487-1491

[25] Aβ immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome [J].

Oddo, S ;

Billings, L ;

Kesslak, JP ;

Cribbs, DH ;

LaFerla, FM .

NEURON, 2004, 43 (03) :321-332

[26] Amyloid-Independent Mechanisms in Alzheimer's Disease Pathogenesis [J].

Pimplikar, Sanjay W. ;

Nixon, Ralph A. ;

Robakis, Nikolaos K. ;

Shen, Jie ;

Tsai, Li-Huei .

JOURNAL OF NEUROSCIENCE, 2010, 30 (45) :14946-14954

[27] Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus [J].

Puzzo, Daniela ;

Privitera, Lucia ;

Leznik, Elena ;

Fa, Mauro ;

Staniszewski, Agnieszka ;

Palmeri, Agostino ;

Arancio, Ottavio .

JOURNAL OF NEUROSCIENCE, 2008, 28 (53) :14537-14545

[28]

REBECK GW, 1993, NEURON, V11, P575

[29] 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study [J].

Rinne, Juha O. ;

Brooks, David J. ;

Rossor, Martin N. ;

Fox, Nick C. ;

Bullock, Roger ;

Klunk, William E. ;

Mathis, Chester A. ;

Blennow, Kaj ;

Barakos, Jerome ;

Okello, Aren A. ;

de Llano, Sofia Rodriguez Martinez ;

Liu, Enchi ;

Koller, Martin ;

Gregg, Keith M. ;

Schenk, Dale ;

Black, Ronald ;

Grundman, Michael .

LANCET NEUROLOGY, 2010, 9 (04) :363-372

[30] Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model [J].

Roberson, Erik D. ;

Scearce-Levie, Kimberly ;

Palop, Jorge J. ;

Yan, Fengrong ;

Cheng, Irene H. ;

Wu, Tiffany ;

Gerstein, Hilary ;

Yu, Gui-Qiu ;

Mucke, Lennart .

SCIENCE, 2007, 316 (5825) :750-754

← 1 2 3 4 →